Engineered Exosomes with Growth Differentiation Factor-15 Overexpression Enhance Cardiac Repair After Myocardial Injury

References

• Zhao M, Nakada Y, Wei Y, et al. Cyclin D2 overexpression enhances the efficacy of human induced pluripotent stem cell-derived cardiomyocytes for myocardial repair in a swine model of myocardial infarction. Circulation. 2021;144(3):210–228. doi:10.1161/CIRCULATIONAHA.120.049497
   PubMed Web of Science ®Google Scholar
• Vogel B, Mehta SR, Mehran R. Reperfusion strategies in acute myocardial infarction and multivessel disease. Nat Rev Cardiol. 2017;14(11):665–678. doi:10.1038/nrcardio.2017.88
   PubMed Web of Science ®Google Scholar
• Ong SB, Hernández-Reséndiz S, Crespo-Avilan GE, et al. Inflammation following acute myocardial infarction: multiple players, dynamic roles, and novel therapeutic opportunities. Pharmacol Ther. 2018;186:73–87. doi:10.1016/j.pharmthera.2018.01.001
   PubMed Web of Science ®Google Scholar
• Khan M, Nickoloff E, Abramova T, et al. Embryonic stem cell-derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction. Circ Res. 2015;117(1):52–64. doi:10.1161/CIRCRESAHA.117.305990
   PubMed Web of Science ®Google Scholar
• Gallet R, Dawkins J, Valle J, et al. Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction. Eur Heart J. 2017;38(3):201–211. doi:10.1093/eurheartj/ehw240
   PubMed Web of Science ®Google Scholar
• Rani S, Ryan AE, Griffin MD, Ritter T. Mesenchymal stem cell-derived extracellular vesicles: toward cell-free therapeutic applications. Mol Ther. 2015;23(5):812–823. doi:10.1038/mt.2015.44
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang L, Li Y, et al. Exosomes/microvesicles from induced pluripotent stem cells deliver cardioprotective miRNAs and prevent cardiomyocyte apoptosis in the ischemic myocardium. Int J Cardiol. 2015;192:61–69. doi:10.1016/j.ijcard.2015.05.020
   PubMed Web of Science ®Google Scholar
• Lou X, Zhao M, Fan C, et al. N-cadherin overexpression enhances the reparative potency of human-induced pluripotent stem cell-derived cardiac myocytes in infarcted mouse hearts. Cardiovasc Res. 2020;116(3):671–685. doi:10.1093/cvr/cvz179
   PubMed Web of Science ®Google Scholar
• Gao L, Gregorich ZR, Zhu W, et al. Large cardiac muscle patches engineered from human induced-pluripotent stem cell-derived cardiac cells improve recovery from myocardial infarction in swine. Circulation. 2018;137(16):1712–1730. doi:10.1161/CIRCULATIONAHA.117.030785
   PubMed Web of Science ®Google Scholar
• Yáñez-Mó M, Siljander PR, Andreu Z, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015;4:27066. doi:10.3402/jev.v4.27066
   PubMed Web of Science ®Google Scholar
• Théry C, Witwer KW, Aikawa E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the international society for extracellular vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7(1):1535750. doi:10.1080/20013078.2018.1535750
   PubMed Web of Science ®Google Scholar
• Maas SLN, Breakefield XO, Weaver AM. Extracellular vesicles: unique intercellular delivery vehicles. Trends Cell Biol. 2017;27(3):172–188. doi:10.1016/j.tcb.2016.11.003
   PubMed Web of Science ®Google Scholar
• Sun L, Zhu W, Zhao P, et al. Long noncoding RNA UCA1 from hypoxia-conditioned hMSC-derived exosomes: a novel molecular target for cardioprotection through miR-873-5p/XIAP axis. Cell Death Dis. 2020;11(8):696. doi:10.1038/s41419-020-02783-5
   PubMed Web of Science ®Google Scholar
• Ibrahim AG, Cheng K, Marbán E. Exosomes as critical agents of cardiac regeneration triggered by cell therapy. Stem Cell Reports. 2014;2(5):606–619. doi:10.1016/j.stemcr.2014.04.006
   PubMed Web of Science ®Google Scholar
• Zhang J, Lu Y, Mao Y, et al. IFN-γ enhances the efficacy of mesenchymal stromal cell-derived exosomes via miR-21 in myocardial infarction rats. Stem Cell Res Ther. 2022;13(1):333. doi:10.1186/s13287-022-02984-z
   PubMed Web of Science ®Google Scholar
• Kempf T, Eden M, Strelau J, et al. The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury. Circ Res. 2006;98(3):351–360. doi:10.1161/01.RES.0000202805.73038.48
   PubMed Web of Science ®Google Scholar
• Xu J, Kimball TR, Lorenz JN, et al. GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation. Circ Res. 2006;98(3):342–350. doi:10.1161/01.RES.0000202804.84885.d0
   PubMed Web of Science ®Google Scholar
• Kempf T, Zarbock A, Widera C, et al. GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice. Nat Med. 2011;17(5):581–588. doi:10.1038/nm.2354
   PubMed Web of Science ®Google Scholar
• Wollert KC, Kempf T, Wallentin L. Growth differentiation factor 15 as a biomarker in cardiovascular disease. Clin Chem. 2017;63(1):140–151. doi:10.1373/clinchem.2016.255174
   PubMed Web of Science ®Google Scholar
• Wollert KC, Kempf T, Peter T, et al. Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome. Circulation. 2007;115(8):962–971. doi:10.1161/CIRCULATIONAHA.106.650846
   PubMed Web of Science ®Google Scholar
• Kurrelmeyer KM, Michael LH, Baumgarten G, et al. Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction. Proc Natl Acad Sci U S A. 2000;97(10):5456–5461. doi:10.1073/pnas.070036297
   PubMed Web of Science ®Google Scholar
• Xiao T, Wei J, Cai D, et al. Extracellular vesicle mediated targeting delivery of growth differentiation factor-15 improves myocardial repair by reprogramming macrophages post myocardial injury. Biomed Pharmacother. 2024;172:116224. doi:10.1016/j.biopha.2024.116224
   PubMed Web of Science ®Google Scholar
• Wang Q, Zhang L, Sun Z, et al. HIF-1α overexpression in mesenchymal stem cell-derived exosome-encapsulated arginine-glycine-aspartate (RGD) hydrogels boost therapeutic efficacy of cardiac repair after myocardial infarction. Mater Today Bio. 2021;12:100171. doi:10.1016/j.mtbio.2021.100171
   PubMedGoogle Scholar
• Sun L, Zhu W, Zhao P, et al. Down-regulated exosomal MicroRNA-221 - 3p derived from senescent mesenchymal stem cells impairs heart repair. Front Cell Dev Biol. 2020;8:263. doi:10.3389/fcell.2020.00263
   PubMed Web of Science ®Google Scholar
• Bär C, Bernardes de Jesus B, Serrano R, et al. Telomerase expression confers cardioprotection in the adult mouse heart after acute myocardial infarction. Nat Commun. 2014;5:5863. doi:10.1038/ncomms6863
   PubMed Web of Science ®Google Scholar
• Leri A, Franco S, Zacheo A, et al. Ablation of telomerase and telomere loss leads to cardiac dilatation and heart failure associated with p53 upregulation. EMBO J. 2003;22(1):131–139. doi:10.1093/emboj/cdg013
   PubMed Web of Science ®Google Scholar
• Oh H, Taffet GE, Youker KA, et al. Telomerase reverse transcriptase promotes cardiac muscle cell proliferation, hypertrophy, and survival. Proc Natl Acad Sci U S A. 2001;98(18):10308–10313. doi:10.1073/pnas.191169098
   PubMed Web of Science ®Google Scholar
• Herbert B, Pitts AE, Baker SI, et al. Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death. Proc Natl Acad Sci U S A. 1999;96(25):14276–14281. doi:10.1073/pnas.96.25.14276
   PubMed Web of Science ®Google Scholar
• Li Q, Li N, Cui HH, et al. Tongxinluo exerts protective effects via anti-apoptotic and pro-autophagic mechanisms by activating AMPK pathway in infarcted rat hearts. Exp Physiol. 2017;102(4):422–435. doi:10.1113/EP086192
   PubMed Web of Science ®Google Scholar
• Liu L, Jin X, Hu CF, Li R, Zhou Z, Shen CX. Exosomes derived from mesenchymal stem cells rescue myocardial ischaemia/reperfusion injury by inducing cardiomyocyte autophagy via AMPK and Akt pathways. Cell Physiol Biochem. 2017;43(1):52–68. doi:10.1159/000480317
   PubMedGoogle Scholar
• Qian L, Huang Y, Spencer CI, et al. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature. 2012;485(7400):593–598. doi:10.1038/nature11044
   PubMed Web of Science ®Google Scholar
• Suleiman M, Khatib R, Agmon Y, et al. Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction predictive role of C-reactive protein. J Am Coll Cardiol. 2006;47(5):962–968. doi:10.1016/j.jacc.2005.10.055
   PubMed Web of Science ®Google Scholar
• Huang P, Wang L, Li Q, et al. Combinatorial treatment of acute myocardial infarction using stem cells and their derived exosomes resulted in improved heart performance. Stem Cell Res Ther. 2019;10(1):300. doi:10.1186/s13287-019-1353-3
   PubMed Web of Science ®Google Scholar
• He JG, Li HR, Han JX, et al. GATA-4-expressing mouse bone marrow mesenchymal stem cells improve cardiac function after myocardial infarction via secreted exosomes. Sci Rep. 2018;8(1):9047. doi:10.1038/s41598-018-27435-9
   PubMedGoogle Scholar
• Zheng YL, Wang WD, Cai PY, et al. Stem cell-derived exosomes in the treatment of acute myocardial infarction in preclinical animal models: a meta-analysis of randomized controlled trials. Stem Cell Res Ther. 2022;13(1):151. doi:10.1186/s13287-022-02833-z
   PubMed Web of Science ®Google Scholar
• Rackov G, Garcia-Romero N, Esteban-Rubio S, Carrión-Navarro J, Belda-Iniesta C, Ayuso-Sacido A. Vesicle-mediated control of cell function: the role of extracellular matrix and microenvironment. Front Physiol. 2018;9:651. doi:10.3389/fphys.2018.00651
   PubMed Web of Science ®Google Scholar
• Antimisiaris SG, Mourtas S, Marazioti A. Exosomes and exosome-inspired vesicles for targeted drug delivery. Pharmaceutics. 2018;10(4):218. doi:10.3390/pharmaceutics10040218
   PubMed Web of Science ®Google Scholar
• Singla DK. Stem cells and exosomes in cardiac repair. Curr Opin Pharmacol. 2016;27:19–23. doi:10.1016/j.coph.2016.01.003
   PubMed Web of Science ®Google Scholar
• Tan SJO, Floriano JF, Nicastro L, Emanueli C, Catapano F. Novel applications of mesenchymal stem cell-derived exosomes for myocardial infarction therapeutics. Biomolecules. 2020;10(5):707. doi:10.3390/biom10050707
   PubMed Web of Science ®Google Scholar
• Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478):eaau6977. doi:10.1126/science.aau6977
   PubMed Web of Science ®Google Scholar
• Figliolini F, Ranghino A, Grange C, et al. Extracellular vesicles from adipose stem cells prevent muscle damage and inflammation in a mouse model of hind limb ischemia: role of Neuregulin-1. Arterioscler Thromb Vasc Biol. 2020;40(1):239–254. doi:10.1161/ATVBAHA.119.313506
   PubMed Web of Science ®Google Scholar
• Bonaterra GA, Zügel S, Thogersen J, et al. Growth differentiation factor-15 deficiency inhibits atherosclerosis progression by regulating interleukin-6-dependent inflammatory response to vascular injury. J Am Heart Assoc. 2012;1(6):e002550. doi:10.1161/JAHA.112.002550
   PubMed Web of Science ®Google Scholar
• Lok SI, Winkens B, Goldschmeding R, et al. Circulating growth differentiation factor-15 correlates with myocardial fibrosis in patients with non-ischaemic dilated cardiomyopathy and decreases rapidly after left ventricular assist device support. Eur J Heart Fail. 2012;14(11):1249–1256. doi:10.1093/eurjhf/hfs120
   PubMed Web of Science ®Google Scholar
• Kempf T, Horn-Wichmann R, Brabant G, et al. Circulating concentrations of growth-differentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich assay. Clin Chem. 2007;53(2):284–291. doi:10.1373/clinchem.2006.076828
   PubMed Web of Science ®Google Scholar
• Berezin AE, Berezin AA. Adverse cardiac remodelling after acute myocardial infarction: old and new biomarkers. Dis Markers. 2020;2020:1215802. doi:10.1155/2020/1215802
   PubMed Web of Science ®Google Scholar
• Bodnar AG, Ouellette M, Frolkis M, et al. Extension of life-span by introduction of telomerase into normal human cells. Science. 1998;279(5349):349–352. doi:10.1126/science.279.5349.349
   PubMed Web of Science ®Google Scholar
• Blasco MA. Telomeres and human disease: ageing, cancer and beyond. Nat Rev Genet. 2005;6(8):611–622. doi:10.1038/nrg1656
   PubMed Web of Science ®Google Scholar
• Goytisolo FA, Samper E, Martín-Caballero J, et al. Short telomeres result in organismal hypersensitivity to ionizing radiation in mammals. J Exp Med. 2000;192(11):1625–1636. doi:10.1084/jem.192.11.1625
   PubMed Web of Science ®Google Scholar
• Minamino T, Miyauchi H, Yoshida T, Ishida Y, Yoshida H, Komuro I. Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction. Circulation. 2002;105(13):1541–1544. doi:10.1161/01.cir.0000013836.85741.17
   PubMed Web of Science ®Google Scholar
• Ogami M, Ikura Y, Ohsawa M, et al. Telomere shortening in human coronary artery diseases. Arterioscler Thromb Vasc Biol. 2004;24(3):546–550. doi:10.1161/01.ATV.0000117200.46938.e7
   PubMed Web of Science ®Google Scholar
• Santos JH, Meyer JN, Skorvaga M, Annab LA, Van Houten B. Mitochondrial hTERT exacerbates free-radical-mediated mtDNA damage. Aging Cell. 2004;3(6):399–411. doi:10.1111/j.1474-9728.2004.00124.x
   PubMed Web of Science ®Google Scholar
• Ale-Agha N, Jakobs P, Goy C, et al. Mitochondrial telomerase reverse transcriptase protects from myocardial ischemia/reperfusion injury by improving complex i composition and function. Circulation. 2021;144(23):1876–1890. doi:10.1161/CIRCULATIONAHA.120.051923
   PubMed Web of Science ®Google Scholar
• Ahmed S, Passos JF, Birket MJ, et al. Telomerase does not counteract telomere shortening but protects mitochondrial function under oxidative stress. J Cell Sci. 2008;121(Pt 7):1046–1053. doi:10.1242/jcs.019372
   PubMed Web of Science ®Google Scholar
• Zhu L, Zang J, Liu B, et al. Oxidative stress-induced RAC autophagy can improve the HUVEC functions by releasing exosomes. J Cell Physiol. 2020;235(10):7392–7409. doi:10.1002/jcp.29641
   PubMed Web of Science ®Google Scholar
• Beyer AM, Norwood Toro LE, Hughes WE, et al. Autophagy, TERT, and mitochondrial dysfunction in hyperoxia. Am J Physiol Heart Circ Physiol. 2021;321(5):H985–H1003. doi:10.1152/ajpheart.00166.2021
   PubMed Web of Science ®Google Scholar
• Moghadasi S, Elveny M, Rahman HS, et al. A paradigm shift in cell-free approach: the emerging role of MSCs-derived exosomes in regenerative medicine. J Transl Med. 2021;19(1):302. doi:10.1186/s12967-021-02980-6
   PubMed Web of Science ®Google Scholar
• Huang P, Wang L, Li Q, et al. Atorvastatin enhances the therapeutic efficacy of mesenchymal stem cells-derived exosomes in acute myocardial infarction via up-regulating long non-coding RNA H19. Cardiovasc Res. 2020;116(2):353–367. doi:10.1093/cvr/cvz139
   PubMed Web of Science ®Google Scholar
• Sun L, Ji Y, Chi B, et al. A 3D culture system improves the yield of MSCs-derived extracellular vesicles and enhances their therapeutic efficacy for heart repair. Biomed Pharmacother. 2023;161:114557. doi:10.1016/j.biopha.2023.114557
   PubMed Web of Science ®Google Scholar
• Chi B, Zou A, Mao L, et al. Empagliflozin-pretreated mesenchymal stem cell-derived small extracellular vesicles attenuated heart injury. Oxid Med Cell Longev. 2023;2023:7747727. doi:10.1155/2023/7747727
   PubMedGoogle Scholar
• Chandy M, Rhee JW, Ozen MO, et al. Atlas of exosomal microRNAs secreted from human iPSC-derived cardiac cell types. Circulation. 2020;142(18):1794–1796. doi:10.1161/CIRCULATIONAHA.120.048364
   PubMed Web of Science ®Google Scholar
• Gao L, Wang L, Wei Y, et al. Exosomes secreted by hiPSC-derived cardiac cells improve recovery from myocardial infarction in swine. Sci Transl Med. 2020;12(561):eaay1318. doi:10.1126/scitranslmed.aay1318
   PubMed Web of Science ®Google Scholar